Literature DB >> 31157257

Investigating the dysfunctional pathogenesis of Wilms' tumor through a multidimensional integration strategy.

Wenbiao Chen1, Jia Zhuang2, Lan Gong3, Yong Dai4, Hongyan Diao1.   

Abstract

BACKGROUND: Wilms' tumor (WT) is a common kidney tumor in early childhood which is characterized by multiple congenital anomalies and syndromes. With the continuous improvement of medical standards, the cure rate and survival period of WT have increased. However, its molecular mechanism is still elusive.
METHODS: A comprehensive multidimensional integration strategy was used to comprehensively analyze the mechanisms of WT.
RESULTS: By integrating the potential pathogenic genes of kidney cancer and performing co-expression analysis on the disease-related genes, 23 functional modules were obtained. All the genes were differentially expressed in WT, and were mainly involved in many biological processes and signaling pathways, such as Wnt/β-catenin, mTOR/ERK and calcineurin. Additionally, based on the relationship between transcriptional and post-transcriptional regulatory systems, in functional modules, transcription factors (TFs) including STAT3, HDAC1 and SP1 as well as non-coding RNAs (ncRNAs) such as miR-335-5p, miR-21-5p and TUG1 were identified. Finally, potential drugs for these multifactor regulated dysfunctional modules which may have certain pharmacological or toxicological effects on WT such as cisplatin, sorafenib, and zinc were predicted.
CONCLUSIONS: A multidimensional dysfunction mechanism, involving disease-related genes, TFs and ncRNAs was revealed in the pathogenesis of WT. Functional modules were used to predict potential drugs which can be used in personalized therapy and drug delivery. This study explored the pathogenesis of WT from a new perspective, and provides new candidate targets and therapeutic drugs for improving the cure rate of WT.

Entities:  

Keywords:  Wilms’ tumor (WT); crosstalk; dysfunctional modules; pivot regulators; potential drugs

Year:  2019        PMID: 31157257      PMCID: PMC6511566          DOI: 10.21037/atm.2019.03.37

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  58 in total

1.  BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks.

Authors:  Steven Maere; Karel Heymans; Martin Kuiper
Journal:  Bioinformatics       Date:  2005-06-21       Impact factor: 6.937

2.  Linear models and empirical bayes methods for assessing differential expression in microarray experiments.

Authors:  Gordon K Smyth
Journal:  Stat Appl Genet Mol Biol       Date:  2004-02-12

3.  Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K/Akt pathway.

Authors:  Yosuke Takano; Kozue Yamauchi; Kunihiro Hayakawa; Nobuhiko Hiramatsu; Ayumi Kasai; Maro Okamura; Makiko Yokouchi; Akihiro Shitamura; Jian Yao; Masanori Kitamura
Journal:  FEBS Lett       Date:  2007-01-12       Impact factor: 4.124

4.  Bone metastases in Wilms' tumour.

Authors:  J V Bond; E C Martin
Journal:  Clin Radiol       Date:  1975-01       Impact factor: 2.350

5.  Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation.

Authors:  Qianghua Hu; Fei Gao; Weihua Tian; E Cristy Ruteshouser; Yaqing Wang; Alexander Lazar; John Stewart; Louise C Strong; Richard R Behringer; Vicki Huff
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

6.  Late toxicity in Wilms tumor patients treated with radiotherapy at 15 years of median follow-up.

Authors:  Giuseppe Sasso; Nicola Greco; Paola Murino; Francesco Silvano Sasso
Journal:  J Pediatr Hematol Oncol       Date:  2010-10       Impact factor: 1.289

Review 7.  Principles of Wilms' tumor biology.

Authors:  M J Coppes; K Pritchard-Jones
Journal:  Urol Clin North Am       Date:  2000-08       Impact factor: 2.241

Review 8.  Wilms' tumor: past, present and (possibly) future.

Authors:  Filippo Spreafico; Franca Fossati Bellani
Journal:  Expert Rev Anticancer Ther       Date:  2006-02       Impact factor: 4.512

9.  Veno-occlusive disease in pediatric patients affected by Wilms tumor.

Authors:  Simone Cesaro; Monica Spiller; Maria Teresa Sartori; Rita Alaggio; Mattia Peruzzo; Graziella Saggiorato; Gianni Bisogno
Journal:  Pediatr Blood Cancer       Date:  2011-01-18       Impact factor: 3.167

Review 10.  [Sporadic aniridia and Wilm's tumor--a case report and review of recommendation for diagnostic approach in WAGR's syndrome].

Authors:  Beata Orawiec; Wojciech Młynarski; Małgorzata Budzińska-Mikurenda; Mirosława Grałek; Beata Szewczyk-Zalewska; Anna Niwald
Journal:  Klin Oczna       Date:  2010
View more
  2 in total

1.  TUG1 Promoted Tumor Progression by Sponging miR-335-5p and Regulating CXCR4-Mediated Infiltration of Pro-Tumor Immunocytes in CTNNB1-Mutated Hepatoblastoma.

Authors:  Fujing Xie; Lianhai Zhang; Qing Yao; Liyu Shan; Jike Liu; Nanhai Dong; Jun Liang
Journal:  Onco Targets Ther       Date:  2020-04-14       Impact factor: 4.147

2.  Identification of the potential novel biomarkers as susceptibility gene for Wilms tumor.

Authors:  Li Liu; Zhe Song; Xu-Dong Gao; Xian Chen; Xiao-Bin Wu; Mi Wang; Yu-De Hong
Journal:  BMC Cancer       Date:  2021-03-25       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.